New Breast Cancer Study Supports A More Gentle Approach to Treatment

//New Breast Cancer Study Supports A More Gentle Approach to Treatment

New Breast Cancer Study Supports A More Gentle Approach to Treatment

A new study published in the New England Journal of Medicine this month is good news for women who want more personalized care for treatment of breast cancer.

10,000 women were followed over 9 years. These women had early stage, receptive to hormones and negative to a receptor called HER2, all characteristics of the most common type of breast cancer. They then had genetic testing and given a score that predicts risk of breast cancer recurrence after surgery. Low scorers can be treated with hormone therapy and high scorers do better with chemotherapy and hormone therapy. The middle scorers were divided into 2 groups – chemo plus hormones or hormones only. After 9 years, the cancer-free rate for both of the groups that scored in the middle after genetic testing were similar, 83-84%.

Side effects from chemotherapy can be very disruptive, so this is study is very exciting for women desiring a more gentle approach.

Lisa Lilienfield, MD

Print this page

About the Author:

Lisa Lilienfield, MD
Lisa Lilienfield, M.D. is board-certified in family medicine and is a member of the American Academy of Medical Acupuncture. Dr. Lilienfield practices Acupuncture and Osteopathic Manipulative Medicine and has developed an expertise in both Women’s Health and Sports Medicine. Dr. Lilienfield also serves as a Clinical Assistant Professor at Georgetown University School of Medicine’s Department of Community and Family Medicine. To read Dr. Lilienfield’s complete bio, click here

Comments